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Background
Helicos Single Molecule Sequencing provides a unique
view of genome biology through direct sequencing of cel-
lular nucleic acids in an unbiased manner, providing
both quantitative and accurate sequence information.
The simple sample preparation involves no ligation or
PCR amplification, allowing direct sequencing of targeted
DNA or RNA molecules. DNA and RNA can be directly
hybridized to the flow cell, eliminating many intermedi-
ary steps that can introduce sample loss or bias. From
these methods, a diverse array of applications have been
successfully demonstrated on the HeliScope Sequencer.
For example, human genome sequencing for accurate
variant detection; multiplexing of DNA for targeted rese-
quencing; copy number variation studies from both fresh
tumor tissue and formalin- fixed paraffin-embedded
tissue samples; RNA-seq studies demonstrating the unex-
plored biology that exists in the transcriptome; small
RNA studies leading to the identification of new classes
of RNAs [1]; and the direct capture and sequencing of
nucleic acid from as few as 400 cells with the end goal of
single cell measurements [2]. Current efforts now focus
on applying these unique attributes to develop novel
substrate for molecular diagnostic tests.
Ongoing programs
Recent studies identified the attributes of the Helicos
Single Molecule Sequencing technology that provide
unique features for molecular diagnostic application
including combining the simplicity of sample prepara-
tion with sequencing, the scalability of the workflow and
the quantitative power of the sequencing. Initially, Heli-
cos is developing a molecular diagnostic test that will
identify gene mutations indicative of a woman’s
increased risk of developing hereditary breast or ovarian
cancer. We are also investigating longer-term studies to
examine the quantitative capabilities of our core tech-
nology in order to develop molecular diagnostic tests
based on the detection and quantification of foreign
DNA/RNA circulating in the bloodstream, such as a
non-invasive prenatal diagnostic test.
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